Cas 55079-50-0,5-[2-(morpholin-4-yl)ethoxy]-2,3-dihydro-1H-inden-1-one hydrochloride

55079-50-0

Post Buying Request

Basic information

Product Name: 5-[2-(morpholin-4-yl)ethoxy]-2,3-dihydro-1H-inden-1-one hydrochloride
Synonyms: 5-[2-(morpholin-4-yl)ethoxy]-2,3-dihydro-1H-inden-1-one hydrochloride
CAS NO:55079-50-0
Molecular Formula:
Molecular Weight: 297.782
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 5-[2-(morpholin-4-yl)ethoxy]-2,3-dihydro-1H-inden-1-one hydrochloride(CAS DataBase Reference)
NIST Chemistry Reference: 5-[2-(morpholin-4-yl)ethoxy]-2,3-dihydro-1H-inden-1-one hydrochloride(55079-50-0)
EPA Substance Registry System: 5-[2-(morpholin-4-yl)ethoxy]-2,3-dihydro-1H-inden-1-one hydrochloride(55079-50-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 55079-50-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

55079-50-0 Suppliers

Recommended suppliers

55079-50-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 55079-50-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,0,7 and 9 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 55079-50:
(7*5)+(6*5)+(5*0)+(4*7)+(3*9)+(2*5)+(1*0)=130
130 % 10 = 0
So 55079-50-0 is a valid CAS Registry Number.

55079-50-0Upstream product

55079-50-0Downstream Products

55079-50-0Relevant academic research and scientific papers

Synthesis and Structure Activity Relationships of Chalcone based Benzocycloalkanone Derivatives as Adenosine A 1 and/or A 2A Receptor Antagonists

Janse Van Rensburg, Helena D.,Legoabe, Lesetja J.,Terre'Blanche, Gisella

, p. 243 - 256 (2020)

Adenosine A 1 and/or A 2A receptor antagonists hold promise for the potential treatment of neurological conditions, such as Parkinson's disease. Herein, a total of seventeen benzocycloalkanone derivatives were synthesised and evaluat

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 55079-50-0